FDA, EMEA To Compare Regulatory Approaches Used For NMEs
This article was originally published in The Tan Sheet
Executive Summary
FDA and the European Medicines Evaluation Agency will conduct a joint assessment of the approaches used by the two agencies in the 1998 cohort of new molecular entity reviews.
You may also be interested in...
International Harmonization Should Focus On Post-Marketing Activities - HRG
International harmonization efforts should include an emphasis on post-marketing activities, Public Citizen's Health Research Group Deputy Director Peter Lurie, MD, commented at an FDA public meeting on the future of the International Conference on Harmonization May 16.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands